These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29644833)

  • 1. GROWTH-INHIBITORY EFFECTS OF FARNESOL AGAINST SCEDOSPORIUM BOYDII AND LOMENTOSPORA PROLIFICANS.
    Pumeesat P; Wongsuk T; Muangkaew W; Luplertlop N
    Southeast Asian J Trop Med Public Health; 2017 Jan; 48(1):170-8. PubMed ID: 29644833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydroorotate dehydrogenase inhibitor F901318 has potent in vitro activity against Scedosporium species and Lomentospora prolificans.
    Wiederhold NP; Law D; Birch M
    J Antimicrob Chemother; 2017 Jul; 72(7):1977-1980. PubMed ID: 28333310
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Furnica DT; Dittmer S; Scharmann U; Meis JF; Steinmann J; Rath PM; Kirchhoff L
    Microbiol Spectr; 2023 Jun; 11(3):e0513022. PubMed ID: 37017567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-Chlorotaurine Exhibits Fungicidal Activity against Therapy-Refractory Scedosporium Species and Lomentospora prolificans.
    Lackner M; Binder U; Reindl M; Gönül B; Fankhauser H; Mair C; Nagl M
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6454-62. PubMed ID: 26239996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conidial germination in Scedosporium apiospermum, S. aurantiacum, S. minutisporum and Lomentospora prolificans: influence of growth conditions and antifungal susceptibility profiles.
    Mello TP; Aor AC; Oliveira SS; Branquinha MH; Santos AL
    Mem Inst Oswaldo Cruz; 2016 Jun; 0(7):0. PubMed ID: 27355215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of the novel antifungal compound F901318 against Australian Scedosporium and Lomentospora fungi.
    Biswas C; Law D; Birch M; Halliday C; Sorrell TC; Rex J; Slavin M; Chen SC
    Med Mycol; 2018 Nov; 56(8):1050-1054. PubMed ID: 29370408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pandemic Response Box® library as a source of antifungal drugs against Scedosporium and Lomentospora species.
    Rollin-Pinheiro R; Xisto MIDDS; de Castro-Almeida Y; Rochetti VP; Borba-Santos LP; Fontes YDS; Ferreira-Pereira A; Rozental S; Barreto-Bergter E
    PLoS One; 2023; 18(2):e0280964. PubMed ID: 36735743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusarium species,Scedosporium species, and Lomentospora prolificans: A systematic review to inform the World Health Organization priority list of fungal pathogens.
    Marinelli T; Kim HY; Halliday CL; Garnham K; Bupha-Intr O; Dao A; Morris AJ; Alastruey-Izquierdo A; Colombo A; Rickerts V; Perfect J; Denning DW; Nucci M; Hamers RL; Cassini A; Oladele R; Sorrell TC; Ramon-Pardo P; Fusire T; Chiller TM; Wahyuningsih R; Forastiero A; Al-Nuseirat A; Beyer P; Gigante V; Beardsley J; Sati H; Alffenaar JW; Morrissey CO
    Med Mycol; 2024 Jun; 62(6):. PubMed ID: 38935914
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Georgacopoulos O; Nunnally N; Law D; Birch M; Berkow EL; Lockhart SR
    Microbiol Spectr; 2023 Feb; 11(1):e0278922. PubMed ID: 36629417
    [No Abstract]   [Full Text] [Related]  

  • 10. Scedosporiosis/lomentosporiosis observational study (SOS): Clinical significance of Scedosporium species identification.
    Bronnimann D; Garcia-Hermoso D; Dromer F; Lanternier F; ;
    Med Mycol; 2021 May; 59(5):486-497. PubMed ID: 33037432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal activity against Scedosporium species and novel assays to assess antifungal pharmacodynamics against filamentous fungi.
    Wiederhold NP; Lewis RE
    Med Mycol; 2009 Jun; 47(4):422-32. PubMed ID: 19058049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of olorofim (F901318) against fungi of the genus, Scedosporium and Rasamsonia as well as against Lomentospora prolificans, Exophiala dermatitidis and azole-resistant Aspergillus fumigatus.
    Kirchhoff L; Dittmer S; Buer J; Rath PM; Steinmann J
    Int J Antimicrob Agents; 2020 Sep; 56(3):106105. PubMed ID: 32721601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of biofilm formation and azoles' susceptibility in Scedosporium/Lomentospora species using an in vitro model that mimics the cystic fibrosis patients' airway environment.
    Mello TP; Lackner M; Branquinha MH; Santos ALS
    J Cyst Fibros; 2021 Mar; 20(2):303-309. PubMed ID: 33334714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of olorofim against clinical isolates of Scedosporium species and Lomentospora prolificans using EUCAST and CLSI methodologies.
    Rivero-Menendez O; Cuenca-Estrella M; Alastruey-Izquierdo A
    J Antimicrob Chemother; 2020 Dec; 75(12):3582-3585. PubMed ID: 32856079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repurposing of auranofin and honokiol as antifungals against
    Yaakoub H; Staerck C; Mina S; Godon C; Fleury M; Bouchara JP; Calenda A
    Virulence; 2021 Dec; 12(1):1076-1090. PubMed ID: 33825667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Photodynamic Therapy on the Growth and Antifungal Susceptibility of Scedosporium and Lomentospora spp.
    Lu Q; Sun Y; Tian D; Xiang S; Gao L
    Mycopathologia; 2017 Dec; 182(11-12):1037-1043. PubMed ID: 28836110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decoding the antifungal resistance mechanisms in biofilms of emerging, ubiquitous and multidrug-resistant species belonging to the Scedosporium/Lomentospora genera.
    Mello TP; Oliveira SSC; Branquinha MH; Santos ALS
    Med Mycol; 2022 Jun; 60(6):. PubMed ID: 35641191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voriconazole plus terbinafine combination antifungal therapy for invasive Lomentospora prolificans infections: analysis of 41 patients from the FungiScope® registry 2008-2019.
    Jenks JD; Seidel D; Cornely OA; Chen S; van Hal S; Kauffman C; Miceli MH; Heinemann M; Christner M; Jover Sáenz A; Burchardt A; Kemmerling B; Herbrecht R; Steinmann J; Shoham S; Gräber S; Pagano L; Deeren D; Aslam S; Taplitz R; Revankar SG; Baddley J; Mehta SR; Reed S; Slavin MA; Hoenigl M
    Clin Microbiol Infect; 2020 Jun; 26(6):784.e1-784.e5. PubMed ID: 31972317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal triazoles and polymorphonuclear leukocytes synergize to cause increased hyphal damage to Scedosporium prolificans and Scedosporium apiospermum.
    Gil-Lamaignere C; Roilides E; Mosquera J; Maloukou A; Walsh TJ
    Antimicrob Agents Chemother; 2002 Jul; 46(7):2234-7. PubMed ID: 12069979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical manifestations and susceptibility of Scedosporium/Lomentospora infections at a tertiary medical centre in Taiwan from 2014 to 2021: A retrospective cohort study.
    Lao CK; Ou JH; Fan YC; Wu TS; Sun PL
    Mycoses; 2023 Oct; 66(10):923-935. PubMed ID: 37449538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.